可溶性白细胞介素-2受体和C反应蛋白水平在淋巴瘤自体外周血干细胞移植选择中的预测作用。 - Suppr

Suppr

超能文献

Predictive role of levels of soluble interleukin-2 receptor and C-reactive protein in selecting autologous PBSC transplantation for lymphoma.

作者信息

Ariizumi H, Saito B, Uto Y, Hattori N, Nakashima H, Yanagisawa K, Harada H, Mori H, Nakamaki T

机构信息

Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.

出版信息

Bone Marrow Transplant. 2015 Feb;50(2):301-3. doi: 10.1038/bmt.2014.236. Epub 2014 Oct 27.

DOI:10.1038/bmt.2014.236

PMID:25347005

Abstract

摘要

相似文献

Predictive role of levels of soluble interleukin-2 receptor and C-reactive protein in selecting autologous PBSC transplantation for lymphoma.

Bone Marrow Transplant. 2015 Feb;50(2):301-3. doi: 10.1038/bmt.2014.236. Epub 2014 Oct 27.

Beta-2 microglobulin predicts the outcome after autologous stem cell transplantation in non-Hodgkin lymphoma.

Transfus Apher Sci. 2015 Feb;52(1):65-71. doi: 10.1016/j.transci.2014.12.007. Epub 2014 Dec 18.

Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma.

Bone Marrow Transplant. 2004 Feb;33(3):291-8. doi: 10.1038/sj.bmt.1704355.

High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.

J Clin Oncol. 1994 Oct;12(10):2176-86. doi: 10.1200/JCO.1994.12.10.2176.

Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma.

Biol Blood Marrow Transplant. 2004 Jun;10(6):386-94. doi: 10.1016/j.bbmt.2004.01.004.

Autologous peripheral blood stem cell harvest and transplant in a patient with cold agglutinin disease secondary to lymphoma.

Transfus Med. 2017 Jun;27(3):222-224. doi: 10.1111/tme.12393. Epub 2017 Feb 7.

Total body irradiation compared with BEAM: Long-term outcomes of peripheral blood autologous stem cell transplantation for non-Hodgkin's lymphoma.

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):513-20. doi: 10.1016/j.ijrobp.2009.08.024. Epub 2010 Feb 4.

[Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma].

Med Clin (Barc). 1998 Jul 11;111(5):161-7.

Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.

Cancer J Sci Am. 1997 Dec;3 Suppl 1:S54-8.

Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation.

Pediatr Blood Cancer. 2013 Dec;60(12):2018-24. doi: 10.1002/pbc.24722. Epub 2013 Aug 30.

引用本文的文献

The Karolinska experience of autologous stem-cell transplantation for lymphoma: a population-based study of all 433 patients 1994-2016.

Exp Hematol Oncol. 2019 Mar 18;8:7. doi: 10.1186/s40164-019-0131-3. eCollection 2019.

Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma.

Ann Oncol. 2016 Jan;27(1):165-72. doi: 10.1093/annonc/mdv486. Epub 2015 Oct 20.

本文引用的文献

Impact of interleukin-6 in hematological malignancies.

Transfus Med Hemother. 2013 Oct;40(5):336-43. doi: 10.1159/000354194. Epub 2013 Jul 19.

Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal type.

PLoS One. 2013 May 28;8(5):e64158. doi: 10.1371/journal.pone.0064158. Print 2013.

Combination chemotherapy increases cytotoxicity of multiple myeloma cells by modification of nuclear factor (NF)-κB activity.

Exp Hematol. 2013 Feb;41(2):209-18. doi: 10.1016/j.exphem.2012.10.002. Epub 2012 Oct 11.

Safety and feasibility of high-dose ranimustine (MCNU), carboplatin, etoposide, and cyclophosphamide (MCVC) therapy followed by autologous stem cell transplantation for malignant lymphoma.

Int J Hematol. 2012 Nov;96(5):624-30. doi: 10.1007/s12185-012-1186-7. Epub 2012 Oct 1.

SIL index, comprising stage, soluble interleukin-2 receptor, and lactate dehydrogenase, is a useful prognostic predictor in diffuse large B-cell lymphoma.

Cancer Sci. 2012 Aug;103(8):1518-23. doi: 10.1111/j.1349-7006.2012.02331.x. Epub 2012 Jul 4.

Serum C-reactive protein as an important prognostic variable in patients with diffuse large B cell lymphoma.

Tumour Biol. 2012 Aug;33(4):1039-44. doi: 10.1007/s13277-012-0337-z. Epub 2012 Feb 11.

Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens.

Ann Hematol. 2012 May;91(5):705-714. doi: 10.1007/s00277-011-1363-4. Epub 2011 Dec 21.

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review.

Biol Blood Marrow Transplant. 2011 Jan;17(1):20-47.e30. doi: 10.1016/j.bbmt.2010.07.008. Epub 2010 Jul 23.

FDG PET/CT versus CT, MR imaging, and 67Ga scintigraphy in the posttherapy evaluation of malignant lymphoma.

Radiographics. 2010 Jul-Aug;30(4):939-57. doi: 10.1148/rg.304095150.

Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: retrospective analysis of the experience of the Fukuoka BMT group.

Bone Marrow Transplant. 2010 Feb;45(2):311-6. doi: 10.1038/bmt.2009.165. Epub 2009 Jul 13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验